Cargando…
Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a progressive autoimmune disease characterized by high levels of antibodies directed against nuclear antigens. Elevated serum CD138, a heparan sulfate–bearing proteoglycan, correlates with increased disease activity in patients with SLE, but the contribution of...
Autores principales: | Liu, Lunhua, Akkoyunlu, Mustafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405997/ https://www.ncbi.nlm.nih.gov/pubmed/34364875 http://dx.doi.org/10.1016/j.jbc.2021.101053 |
Ejemplares similares
-
Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus
por: Liu, Lunhua, et al.
Publicado: (2020) -
Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse
por: Liu, Lunhua, et al.
Publicado: (2018) -
Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus
por: Xu, Shu, et al.
Publicado: (2020) -
Diversity, cellular origin and autoreactivity of antibody-secreting cell expansions in acute Systemic Lupus Erythematosus
por: Tipton, Christopher M, et al.
Publicado: (2015) -
CD138 promotes the accumulation and activation of autoreactive T cells in autoimmune MRL/lpr mice
por: Xie, Tianhong, et al.
Publicado: (2023)